| YAP1 and COX2 coordinately regulate urothelial cancer stem-like cells A Ooki, M Del Carmen Rodriguez Pena, L Marchionni, W Dinalankara, ... Cancer research 78 (1), 168-181, 2018 | 91 | 2018 |
| Influenza Vaccination and COVID19 Mortality in the USA C Zanettini, M Omar, W Dinalankara, EL Imada, E Colantuoni, ... MedRxiv, 2020 | 86 | 2020 |
| Influenza vaccination and COVID-19 mortality in the USA: an ecological study C Zanettini, M Omar, W Dinalankara, EL Imada, E Colantuoni, ... Vaccines 9 (5), 427, 2021 | 49 | 2021 |
| Epigenetically regulated PAX6 drives cancer cells toward a stem-like state via GLI-SOX2 signaling axis in lung adenocarcinoma A Ooki, W Dinalankara, L Marchionni, JCJ Tsay, C Goparaju, Z Maleki, ... Oncogene 37 (45), 5967-5981, 2018 | 49 | 2018 |
| PDCD4 is an androgen-repressed tumor suppressor that regulates prostate cancer growth and castration resistance K Zennami, SM Choi, R Liao, Y Li, W Dinalankara, L Marchionni, ... Molecular Cancer Research 17 (2), 618-627, 2019 | 34 | 2019 |
| MicroRNA expression profiling of Xp11 renal cell carcinoma L Marchionni, M Hayashi, E Guida, A Ooki, E Munari, FJ Jabboure, ... Human pathology 67, 18-29, 2017 | 28 | 2017 |
| Digitizing omics profiles by divergence from a baseline W Dinalankara, Q Ke, Y Xu, L Ji, N Pagane, A Lien, T Matam, EJ Fertig, ... Proceedings of the National Academy of Sciences 115 (18), 4545-4552, 2018 | 26 | 2018 |
| Gene expression signatures based on variability can robustly predict tumor progression and prognosis W Dinalankara, HC Bravo Cancer informatics 14, CIN. S23862, 2015 | 22 | 2015 |
| Recounting the FANTOM CAGE-associated transcriptome EL Imada, DF Sanchez, L Collado-Torres, C Wilks, T Matam, ... Genome research 30 (7), 1073-1081, 2020 | 21 | 2020 |
| The metacognitive loop: An architecture for building robust intelligent systems H Haidarian, W Dinalankara, S Fults, S Wilson, D Perlis, M Schmill, ... PAAAI Fall Symposium on Commonsense Knowledge (AAAI/CSK’10), 2010 | 20 | 2010 |
| Influenza Vaccination and COVID19 Mortality in the USA. medRxiv 2020 C Zanettini, M Omar, W Dinalankara, EL Imada, E Colantuoni, ... Google Scholar, 0 | 20 | |
| Transcriptional landscape of PTEN loss in primary prostate cancer EL Imada, DF Sanchez, W Dinalankara, T Vidotto, EM Ebot, ... BMC cancer 21, 1-13, 2021 | 16 | 2021 |
| Identifying personalized metabolic signatures in breast cancer P Baloni, W Dinalankara, JC Earls, TA Knijnenburg, D Geman, ... Metabolites 11 (1), 20, 2020 | 11 | 2020 |
| Using biological constraints to improve prediction in precision oncology M Omar, W Dinalankara, L Mulder, T Coady, C Zanettini, EL Imada, ... Iscience 26 (3), 2023 | 6* | 2023 |
| Efficient representations of tumor diversity with paired DNA-RNA aberrations Q Ke, W Dinalankara, L Younes, D Geman, L Marchionni PLoS computational biology 17 (6), e1008944, 2021 | 3 | 2021 |
| An R package for divergence analysis of omics data W Dinalankara, Q Ke, D Geman, L Marchionni PloS one 16 (4), e0249002, 2021 | 2 | 2021 |
| Differential analysis of gene expression across the human genome using recount2 and FANTOM-CAT E Luidy-Imada, T Matam, L Collado-Torres, W Dinalankara, A Stupnikov, ... Cancer Research 78 (13_Supplement), 2297-2297, 2018 | 2 | 2018 |
| Distinct mesenchymal cell states mediate prostate cancer progression H Pakula, M Omar, R Carelli, F Pederzoli, GN Fanelli, T Pannellini, ... Nature Communications 15 (1), 363, 2024 | 1 | 2024 |
| Efficient Representations of Tumor Diversity with Paired DNA-RNA Anomalies Q Ke, W Dinalankara, L Younes, D Geman, L Marchionni bioRxiv, 2020 | 1 | 2020 |
| Anti-Profiles for Anomaly Classification and Regression W Dinalankara | 1 | 2015 |
